New web client makes mobile team project work possible
SAP Announces First of a New Generation of Business Applications Harnessing In-Memory Computing, Enables Companies to Re-Think Layers and Complexity of the Traditional IT Stack
Highest quality and process stability is the key to success for Heraeus bonding wires
Frankfurt/Beijing, November 30, 2010 ? the joint venture Original1 is celebrating the foundation of its first foreign branch with the grand opening of its office in Beijing. This is the result of the expansion of the Software-as-a-Service range to include the authentication of identity documents in China. As the provider of the leading platform for product information for brand protection, Original1 is a thought leader in the market. Its self-developed Global Brand Protection Service of
CompuGroup Medical invests 130 million euros in the healthcare system – part 3
DESIGNA Verkehrsleittechnik GmbH has expanded its international presence by taking over Mainz-based ASYTEC GmbH, a manufacturer of parking management and access control systems.
ROTEC GmbH & Co. KG is completely certified according to ISO 9001:2008.
Since early September 2009 Dipl.-Ing. Guido Runkel has been supporting Mr Paul-Horst Kann in the management of ROTEC GmbH & Co. KG. With the arrival of Mr. Runkel as CEO, the overall direction of Rotec has been redefined. In this context, the production plant for expanded silicate granulates and dry fills of the quick-mix Kruft GmbH & Co. KG was acquired on the first of March of this year. This Neuwied company h
Tuesday&Wednesday, December 7th&8th, 2010 – Munich
Monday, December 6th, 2010 – Munich
AiCuris GmbH & Co. KG has been awarded a three-year research grant together with the Universities of Bochum, Düsseldorf and Bonn as well as the company Squarix (Marl). This grant is a part of the research promotion program "Bio.NRW" by the Ministry of Innovation, Science and Research of North Rhine-Westphalia. AiCuris will obtain 833,582 Euro. The project "Innovative Antibiotics made in NRW" is aimed to enable research and development of new antibiotics effe